Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BOTOX® in the Treatment of Urinary Incontinence Due to Overactive Bladder in Patients 12 to 17 Years of Age

NCT02097121 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT02097121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02097121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BOTOX® in the Treatment of Urinary Incontinence Due to Overactive Bladder in Patients 12 to 17 Years of Age
Lead sponsor
Allergan
Phase
Phase 3
Overall status
Terminated
Start date
May 23, 2014
Completion date
February 10, 2022
Enrollment
56 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

overactive, urinary bladder, urinary incontinence